Boston Scientific Cardiovascular — Other segment items increased by 16.7% to $7.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 40.0%, from $5.00M to $7.00M. Over 3 years (FY 2022 to FY 2025), Cardiovascular — Other segment items shows an upward trend with a 4.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising non-operating costs or one-time charges, while a decrease suggests lower peripheral expenses.
This metric represents miscellaneous income or expense items specifically attributed to the cardiovascular business segm...
Similar to 'Other Operating Income/Expense' found in segment reporting for medical device peers.
bsx_segment_cardiovascular_other_segment_items| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.50M | $5.50M | $5.50M | $5.50M | $5.75M | $5.75M | $5.75M | $5.75M | $4.00M | $5.00M | $5.00M | $5.00M | $6.00M | $6.00M | $6.00M | $7.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +4.5% | +0.0% | +0.0% | +0.0% | -30.4% | +25.0% | +0.0% | +0.0% | +20.0% | +0.0% | +0.0% | +16.7% |
| YoY Change | — | — | — | — | +4.5% | +4.5% | +4.5% | +4.5% | -30.4% | -13.0% | -13.0% | -13.0% | +50.0% | +20.0% | +20.0% | +40.0% |